Sep. 1 at 8:44 PM
Interactive Brokers shares fell during midday trading as several bearish factors hit simultaneously. The stock went ex-dividend for its quarterly
$0.0875-per-share cash payout, while Goldman Sachs removed IBKR from its Director’s Cut list of high-conviction Buy-rated U.S. stocks, replacing it with Vertex Pharmaceuticals, signaling weaker near-term conviction.
UBS also initiated coverage with a Neutral rating and a
$102 price target, saying IBKR has a strong operating profile but appears fully valued. UBS expects 10%–13% average EPS growth through 2030, supported by account expansion, higher client assets and trading activity, but sees limited upside because the stock trades at a significant premium to peers. Recent insider selling totaling about
$99 million over the past 12 months added to investor concerns.
$IBKR